-
1
-
-
0033540056
-
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
-
Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
-
(1999)
Nature
, vol.402
, pp. 656-660
-
-
Kojima, M.1
Hosoda, H.2
Date, Y.3
Nakazato, M.4
Matsuo, H.5
Kangawa, K.6
-
2
-
-
29144466031
-
Functional and immunocytochemical evidence for a role of ghrelin and des-octanoyl ghrelin in the regulation of vascular tone in man
-
Kleinz M.J., Maguire J.J., Skepper J.N., Davenport A.P. Functional and immunocytochemical evidence for a role of ghrelin and des-octanoyl ghrelin in the regulation of vascular tone in man. Cardiovasc Res 2006, 69:227-235.
-
(2006)
Cardiovasc Res
, vol.69
, pp. 227-235
-
-
Kleinz, M.J.1
Maguire, J.J.2
Skepper, J.N.3
Davenport, A.P.4
-
3
-
-
3042735648
-
The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans
-
Gnanapavan S., Kola B., Bustin S.A., Morris D.G., McGee P., Fairclough P., Bhattacharya S., Carpenter R., Grossman A.B., Korbonits M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metabol 2002, 87:2988-2991.
-
(2002)
J Clin Endocrinol Metabol
, vol.87
, pp. 2988-2991
-
-
Gnanapavan, S.1
Kola, B.2
Bustin, S.A.3
Morris, D.G.4
McGee, P.5
Fairclough, P.6
Bhattacharya, S.7
Carpenter, R.8
Grossman, A.B.9
Korbonits, M.10
-
4
-
-
70649098385
-
Expression of ghrelin and its receptor in human tissues
-
Ueberberg B., Unger N., Saeger W., Mann K., Petersenn S. Expression of ghrelin and its receptor in human tissues. Horm Metab Res 2009, 41:814-821.
-
(2009)
Horm Metab Res
, vol.41
, pp. 814-821
-
-
Ueberberg, B.1
Unger, N.2
Saeger, W.3
Mann, K.4
Petersenn, S.5
-
5
-
-
2442515963
-
Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes
-
Iglesias M.J., Piñeiro R., Blanco M., Gallego R., Diéguez C., Gualillo O., González-Juanatey J.R., Lago F. Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes. Cardiovasc Res 2004, 62:481-488.
-
(2004)
Cardiovasc Res
, vol.62
, pp. 481-488
-
-
Iglesias, M.J.1
Piñeiro, R.2
Blanco, M.3
Gallego, R.4
Diéguez, C.5
Gualillo, O.6
González-Juanatey, J.R.7
Lago, F.8
-
6
-
-
84855199907
-
Ghrelin and cardiovascular diseases
-
Kishimoto I., Tokudome T., Hosoda H., Miyazato M., Kangawa K. Ghrelin and cardiovascular diseases. J Cardiol 2012, 59(1):8-13.
-
(2012)
J Cardiol
, vol.59
, Issue.1
, pp. 8-13
-
-
Kishimoto, I.1
Tokudome, T.2
Hosoda, H.3
Miyazato, M.4
Kangawa, K.5
-
7
-
-
84905266375
-
Mechanisms of ghrelin anti-heart failure: inhibition of Ang II-induced cardiomyocyte apoptosis by down-regulating AT1R expression
-
Yang Chunyan, Liu Zhonghui, Liu Kai, Yang Ping Mechanisms of ghrelin anti-heart failure: inhibition of Ang II-induced cardiomyocyte apoptosis by down-regulating AT1R expression. PLoS One 2014, 9(1):e85785.
-
(2014)
PLoS One
, vol.9
, Issue.1
-
-
Yang, C.1
Liu, Z.2
Liu, K.3
Yang, P.4
-
8
-
-
53249154955
-
Early ghrelin treatment after myocardial infarction prevents an increase in cardiac sympathetic tone and reduces mortality
-
Schwenke D.O., Tokudome T., Kishimoto I., Horio T., Shirai M., Cragg P.A., Kangawa K. Early ghrelin treatment after myocardial infarction prevents an increase in cardiac sympathetic tone and reduces mortality. Endocrinology 2008, 149:5172-5176.
-
(2008)
Endocrinology
, vol.149
, pp. 5172-5176
-
-
Schwenke, D.O.1
Tokudome, T.2
Kishimoto, I.3
Horio, T.4
Shirai, M.5
Cragg, P.A.6
Kangawa, K.7
-
9
-
-
20844460120
-
Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure
-
Nagaya N., Moriya J., Yasumura Y., Uematsu M., Ono F., Shimizu W., Ueno K., Kitakaze M., Miyatake K., Kangawa K. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 2004, 110:3674-3679.
-
(2004)
Circulation
, vol.110
, pp. 3674-3679
-
-
Nagaya, N.1
Moriya, J.2
Yasumura, Y.3
Uematsu, M.4
Ono, F.5
Shimizu, W.6
Ueno, K.7
Kitakaze, M.8
Miyatake, K.9
Kangawa, K.10
-
10
-
-
70449656984
-
Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect
-
Huang C.X., Yuan M.J., Huang H., Wu G., Liu Y., Yu S.B., Li H.T., Wang T. Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect. Peptides 2009, 30:2286-2291.
-
(2009)
Peptides
, vol.30
, pp. 2286-2291
-
-
Huang, C.X.1
Yuan, M.J.2
Huang, H.3
Wu, G.4
Liu, Y.5
Yu, S.B.6
Li, H.T.7
Wang, T.8
-
11
-
-
68949167649
-
A novel peptide ghrelin inhibits neural remodeling after myocardial infarction in rats
-
Yuan M.J., Huang C.X., Tang Y.H., Wang X., Huang H., Chen Y.J., Wang T. A novel peptide ghrelin inhibits neural remodeling after myocardial infarction in rats. Eur J Pharmacol 2009, 618:52-57.
-
(2009)
Eur J Pharmacol
, vol.618
, pp. 52-57
-
-
Yuan, M.J.1
Huang, C.X.2
Tang, Y.H.3
Wang, X.4
Huang, H.5
Chen, Y.J.6
Wang, T.7
-
12
-
-
78049483949
-
Altered myocardial expression of ghrelin and its receptor (GHSR-1a) in patients with severe heart failure
-
Beiras-Fernandez A., Kreth S., Weis F., Ledderose C., Pöttinger T., Dieguez C., Beiras A., Reichart B. Altered myocardial expression of ghrelin and its receptor (GHSR-1a) in patients with severe heart failure. Peptides 2010, 31:2222-2228.
-
(2010)
Peptides
, vol.31
, pp. 2222-2228
-
-
Beiras-Fernandez, A.1
Kreth, S.2
Weis, F.3
Ledderose, C.4
Pöttinger, T.5
Dieguez, C.6
Beiras, A.7
Reichart, B.8
-
13
-
-
70749095878
-
No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure
-
Akashi Y.J., Palus S., Datta R., Halem H., Taylor J.E., Thoene-Reineke C., Dong J., Thum T., Culler M.D., Anker S.D., Springer J. No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure. Int J Cardiol 2009, 137:267-275.
-
(2009)
Int J Cardiol
, vol.137
, pp. 267-275
-
-
Akashi, Y.J.1
Palus, S.2
Datta, R.3
Halem, H.4
Taylor, J.E.5
Thoene-Reineke, C.6
Dong, J.7
Thum, T.8
Culler, M.D.9
Anker, S.D.10
Springer, J.11
-
14
-
-
0035710746
-
Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-delta delta C) method
-
Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-delta delta C) method. Methods 2001, 25:402-408.
-
(2001)
Methods
, vol.25
, pp. 402-408
-
-
Livak, K.J.1
Schmittgen, T.D.2
-
15
-
-
84859788175
-
Ghrelin signaling in heart remodeling of adult obese mice
-
Lacerda-Miranda G., Soares V.M., Vieira A.K., Lessa J.G., Rodrigues-Cunha A.C., Cortez E., Garcia-Souza E.P., Moura A.S. Ghrelin signaling in heart remodeling of adult obese mice. Peptides 2012, 35:65-73.
-
(2012)
Peptides
, vol.35
, pp. 65-73
-
-
Lacerda-Miranda, G.1
Soares, V.M.2
Vieira, A.K.3
Lessa, J.G.4
Rodrigues-Cunha, A.C.5
Cortez, E.6
Garcia-Souza, E.P.7
Moura, A.S.8
-
16
-
-
84866434902
-
The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanism
-
Deboer M.D. The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanism. Curr Pharm Des 2012, 18:4779-4799.
-
(2012)
Curr Pharm Des
, vol.18
, pp. 4779-4799
-
-
Deboer, M.D.1
-
17
-
-
77249162694
-
Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction
-
Kanashiro-Takeuchi R.M., Tziomalos K., Takeuchi L.M., Treuer A.V., Lamirault G., Dulce R., Hurtado M., Song Y., Block N.L., Rick F., Klukovits A., Hu Q., Varga J.L., Schally A.V., Hare J.M. Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction. Proc Natl Acad Sci U S A 2010, 107:2604-2609.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 2604-2609
-
-
Kanashiro-Takeuchi, R.M.1
Tziomalos, K.2
Takeuchi, L.M.3
Treuer, A.V.4
Lamirault, G.5
Dulce, R.6
Hurtado, M.7
Song, Y.8
Block, N.L.9
Rick, F.10
Klukovits, A.11
Hu, Q.12
Varga, J.L.13
Schally, A.V.14
Hare, J.M.15
-
18
-
-
84862791011
-
Ghrelin promotes the differentiation of human embryonic stem cells in infarcted cardiac microenvironment
-
Gao M., Yang J., Liu G., Wei R., Zhang L., Wang H., Wang G., Gao H., Chen G., Hong T. Ghrelin promotes the differentiation of human embryonic stem cells in infarcted cardiac microenvironment. Peptides 2012, 34:373-379.
-
(2012)
Peptides
, vol.34
, pp. 373-379
-
-
Gao, M.1
Yang, J.2
Liu, G.3
Wei, R.4
Zhang, L.5
Wang, H.6
Wang, G.7
Gao, H.8
Chen, G.9
Hong, T.10
-
19
-
-
84859485950
-
Growth hormone secretagogues protect mouse cardiomyocytes from in vitro ischemia/reperfusion injury through regulation of intracellular calcium
-
Ma Y., Zhang L., Edwards J.N., Launikonis B.S., Chen C. Growth hormone secretagogues protect mouse cardiomyocytes from in vitro ischemia/reperfusion injury through regulation of intracellular calcium. PLoS One 2012, 7:e35265.
-
(2012)
PLoS One
, vol.7
-
-
Ma, Y.1
Zhang, L.2
Edwards, J.N.3
Launikonis, B.S.4
Chen, C.5
-
20
-
-
67650257490
-
Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart
-
Granata R., Trovato L., Gallo M.P., Destefanis S., Settanni F., Scarlatti F., Brero A., Ramella R., Volante M., Isgaard J., Levi R., Papotti M., Alloatti G., Ghigo E. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart. Cardiovasc Res 2009, 83:303-312.
-
(2009)
Cardiovasc Res
, vol.83
, pp. 303-312
-
-
Granata, R.1
Trovato, L.2
Gallo, M.P.3
Destefanis, S.4
Settanni, F.5
Scarlatti, F.6
Brero, A.7
Ramella, R.8
Volante, M.9
Isgaard, J.10
Levi, R.11
Papotti, M.12
Alloatti, G.13
Ghigo, E.14
-
21
-
-
84855998730
-
Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI)
-
Kanashiro-Takeuchi Rosemeire M., Takeuchi Lauro M., Rick Ferenc G., Dulce Raul, Treuer Adriana V., Florea Victoria, Rodrigues Claudia O., Paulino Ellena C., Hatzistergos Konstantinos E., Selem Sarah M., Gonzalez Daniel R., Block Norman L., Schally Andrew V., Hare Joshua M. Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI). Proc Natl Acad Sci U S A 2012, 109:559-563.
-
(2012)
Proc Natl Acad Sci U S A
, vol.109
, pp. 559-563
-
-
Kanashiro-Takeuchi, R.M.1
Takeuchi, L.M.2
Rick, F.G.3
Dulce, R.4
Treuer, A.V.5
Florea, V.6
Rodrigues, C.O.7
Paulino, E.C.8
Hatzistergos, K.E.9
Selem, S.M.10
Gonzalez, D.R.11
Block, N.L.12
Schally, A.V.13
Hare, J.M.14
-
22
-
-
84862740198
-
Ghrelin prevents incidence of malignant arrhythmia after acute myocardial infarction through vagal afferent nerves
-
Mao Y., Tokudome T., Otani K., Kishimoto I., Nakanishi M., Hosoda H., Miyazato M., Kangawa K. Ghrelin prevents incidence of malignant arrhythmia after acute myocardial infarction through vagal afferent nerves. Endocrinology 2012, 153:3426-3434.
-
(2012)
Endocrinology
, vol.153
, pp. 3426-3434
-
-
Mao, Y.1
Tokudome, T.2
Otani, K.3
Kishimoto, I.4
Nakanishi, M.5
Hosoda, H.6
Miyazato, M.7
Kangawa, K.8
-
23
-
-
84861082286
-
Ghrelin protects H9c2 cardiomyocytes from angiotensin II-induced apoptosis through the endoplasmic reticulum stress pathway
-
Yang C., Wang Y., Liu H., Li N., Sun Y., Liu Z., Yang P. Ghrelin protects H9c2 cardiomyocytes from angiotensin II-induced apoptosis through the endoplasmic reticulum stress pathway. J Cardiovasc Pharmacol 2012, 59:465-471.
-
(2012)
J Cardiovasc Pharmacol
, vol.59
, pp. 465-471
-
-
Yang, C.1
Wang, Y.2
Liu, H.3
Li, N.4
Sun, Y.5
Liu, Z.6
Yang, P.7
-
24
-
-
5444263815
-
There are no acute cardiac effects of a single iv dose of human ghrelin in severe growth hormone deficient patients
-
Janssen J.A., Poldermans D., Hofland L.J., Vourvouri E.C., Muller A.F., Bax J.J., Deghenghi R., Broglio F., Ghigo E., van der Lely A.J. There are no acute cardiac effects of a single iv dose of human ghrelin in severe growth hormone deficient patients. J Endocrinol Invest 2004, 27:659-664.
-
(2004)
J Endocrinol Invest
, vol.27
, pp. 659-664
-
-
Janssen, J.A.1
Poldermans, D.2
Hofland, L.J.3
Vourvouri, E.C.4
Muller, A.F.5
Bax, J.J.6
Deghenghi, R.7
Broglio, F.8
Ghigo, E.9
van der Lely, A.J.10
-
25
-
-
0038410093
-
Ghrelin plays a minor role in the physiological control of cardiac function in the rat
-
Torsello A., Bresciani E., Rossoni G., Avallone R., Tulipano G., Cocchi D., Bulgarelli I., Deghenghi R., Berti F., Locatelli V. Ghrelin plays a minor role in the physiological control of cardiac function in the rat. Endocrinology 2003, 144:1787-1792.
-
(2003)
Endocrinology
, vol.144
, pp. 1787-1792
-
-
Torsello, A.1
Bresciani, E.2
Rossoni, G.3
Avallone, R.4
Tulipano, G.5
Cocchi, D.6
Bulgarelli, I.7
Deghenghi, R.8
Berti, F.9
Locatelli, V.10
-
26
-
-
0035940390
-
Elevated circulating level of ghrelin in cachexia associated with chronic heart failure-relationships between ghrelin and anabolic/catabolic factors
-
Nagaya N., Uematsu M., Kojima M., Date Y., Nakazato M., Okumura H., Hosoda H., Shimizu W., Yamagishi M., Oya H., Koh H., Yutani C., Kangawa K. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure-relationships between ghrelin and anabolic/catabolic factors. Circulation 2001, 104:2034-2038.
-
(2001)
Circulation
, vol.104
, pp. 2034-2038
-
-
Nagaya, N.1
Uematsu, M.2
Kojima, M.3
Date, Y.4
Nakazato, M.5
Okumura, H.6
Hosoda, H.7
Shimizu, W.8
Yamagishi, M.9
Oya, H.10
Koh, H.11
Yutani, C.12
Kangawa, K.13
-
27
-
-
34247200939
-
Endogenous ghrelin increases in adriamycin-induced heart failure rats
-
Xu Z., Wu W., Zhang X., Liu G. Endogenous ghrelin increases in adriamycin-induced heart failure rats. J Endocrinol Invest 2007, 30:117-125.
-
(2007)
J Endocrinol Invest
, vol.30
, pp. 117-125
-
-
Xu, Z.1
Wu, W.2
Zhang, X.3
Liu, G.4
-
28
-
-
67749084358
-
Ghrelin resistance occurs in severe heart failure and resolves after heart transplantation
-
Lund L.H., Williams J.J., Freda P., LaManca J.J., LeJemtel T.H., Mancini D.M. Ghrelin resistance occurs in severe heart failure and resolves after heart transplantation. Eur J Heart Fail 2009, 11:789-794.
-
(2009)
Eur J Heart Fail
, vol.11
, pp. 789-794
-
-
Lund, L.H.1
Williams, J.J.2
Freda, P.3
LaManca, J.J.4
LeJemtel, T.H.5
Mancini, D.M.6
-
29
-
-
84887597788
-
Decreased serum ghrelin levels in patients with acute myocardial infarction
-
Matsumoto M., Yasuda S., Miyazaki S., Kataoka Y., Hosoda H., Nagaya N., Noguchi T., Morii I., Ogawa H., Kangawa K. Decreased serum ghrelin levels in patients with acute myocardial infarction. Tohoku J Exp Med 2013, 231:235-242.
-
(2013)
Tohoku J Exp Med
, vol.231
, pp. 235-242
-
-
Matsumoto, M.1
Yasuda, S.2
Miyazaki, S.3
Kataoka, Y.4
Hosoda, H.5
Nagaya, N.6
Noguchi, T.7
Morii, I.8
Ogawa, H.9
Kangawa, K.10
-
30
-
-
84896460683
-
The growth hormone secretagogue receptor: its intracellular signaling and regulation
-
Yin Yue, Li Yin, Zhang Weizhen The growth hormone secretagogue receptor: its intracellular signaling and regulation. Int J Mol Sci 2014, 15:4837-4855.
-
(2014)
Int J Mol Sci
, vol.15
, pp. 4837-4855
-
-
Yin, Y.1
Li, Y.2
Zhang, W.3
|